FDA Investigator Carol Mrivera Lopez, PhD
Carol Mrivera Lopez, PhD has inspections in 1 countries as of 18 Apr 2023. Carol Mrivera Lopez, PhD has collaborated with a combinined 2115 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
18 Apr 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aimee J Edwin,
Albert F Peacock, PhD,
Ana P Barido,
Andrea A Branche,
Arindam Dasgupta, PhD,
Barbara A Rusin,
Barbara J Holladay,
Brandon L Mariner,
Brooke K Higgins,
Byron Ho, DVM,
Candice C Mandera,
Candice C Mandero,
Candice J Cortes,
Carla C Tuite,
Carol Rivera Lopez, PhD,
Catherine Whiteside, PhD,
Charles A Snipes, PhD,
Charles Kerns,
Charles M Kerns, BLT DO,
Christine M Smith,
Christine M Whitby, CSO,
Corey K Reno,
Cynthia A Harris, MD, RN,
D'arbra R Blankenship,
Da Lin Yao, MD, PhD,
Darren D Holaday,
David K Glasgow,
Dawn C Olenjack,
Dianne H Milazzo,
Dina A Tallman,
Douglas W Gronski,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Hansong Chen, PhD,
Dr. Mark J Seaton, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dylan D Yao, MD, PhD,
Elise A Murphy,
Emest F Bizjak,
Eric S Pittman,
Gajendiran Mahadevan, PhD,
Geoffrey K Kilili,
Gifford Whitehurst, Jr,
Gopa Bisivas,
Gregory S Larson,
Hector J Colon Torres,
Hugh M Mcclure, II,
Huixia Zhang,
Jackie O'shaughnessy,
Jacqueline A O'shanghnessy, PhD,
Jacqueline A O'shaughnessy, PhD,
Jacqueline N O'shaughnessy,
Janet L Bowen,
Jaqueline A O'shaughnessy,
Jennifer Alongie Vollom,
Jodi M Gatica,
John A Kadavil, PhD,
John J Walsh,
John J Welsh, PhD,
John Kadavil, PhD,
Joseph R Haynes,
Karen M Cooper,
Karen M Kondas,
Kenneth Nieves,
Lisa B Orr,
LT Melanie M Mayor, USPHS,
Lynette P Salisbury,
Martin K Yau, PhD,
Mathew R Manen,
Matthew R Mcnew,
Melissa J Garcia,
Michael F Skelly, PhD,
Mishelle L Harriger,
Nancy A Bellamy,
Natalie A Mickelsen, DVM,
Nathaniel R Esaw,
Niraj Mehta,
Patrick D Stone, MS,
Robert Barron,
Sam H Haidar, PhD,
Samuel H Chan, PharmD,
Scott B Laufenberg,
Sean Y Kassim, PhD,
Sharon L Matson,
Sharon M Harold,
Sherry I Seerist,
Sherry L Secrist, BLT DO,
Srinivas R Chennamaneni, PhD,
Sripal R Mada, PhD,
Stephanie Mangigian, MS/OSH, RN,
Stephen J Kilker,
Steven J Thurber,
Tamal K Chakraborti, PhD,
Tamika E Allen, RN,
Tanika E Allen, RN,
Tara C Singh,
Tracey Asinjen Wiersma,
Traci C Kelm,
Tracy L Taras,
William D Tingley,
William H Linkroum,
Xikui Chen (nmi), PhD,
Yih Chain Huang, PhD,
Yvette Mlacour Davis
Carol Mrivera Lopez, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2010 | FDA 483 | Charles River Laboratories - Form 483, 2010-07-07 |
March, 2010 | EIR | PRACS Institute, Ltd. - EIR, 2010-03-25 |
July, 2009 | FDA 483 | Covance Laboratories, Inc. - Form 483, 2009-07-22 |
July, 2010 | EIR | Charles River Laboratories - EIR, 2010-07-07 |
January, 2010 | FDA 483 | PPD Development, L.P. - Form 483, 2010-01-08 |
October, 2009 | EIR | Charles River Laboratories Ashland, LLC - EIR, 2009-10-30 |
May, 2010 | FDA 483 | Cetero Research - Form 483, 2010-05-07 |
January, 2010 | EIR | PPD Development, L.P. - EIR, 2010-01-08 |
July, 2009 | EIR | Covance Laboratories, Inc. - EIR, 2009-07-22 |
October, 2009 | FDA 483 | Charles River Laboratories Ashland, LLC - Form 483, 2009-10-30 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more